EDX Medical Group Plc

AQSE Growth Market -
EDX Medical develops and delivers innovative digital diagnostic products and services for cancer, heart disease, neurology and infectious disease testing, helping to predict disease risk, inform clinical decision-making and accelerate the development of new medicines.

By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection of disease risk and personalise disease management in a timely fashion. Early disease detection and risk prediction is the most impactful way of reducing deaths and lowering the future costs of healthcare provision globally.

EDX Medical operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development (R&D), provides testing and genomic sequencing services, undertakes quality assurance and has established expertise in the design, development, validation and sourcing of diagnostic tests at commercial scale. Key tests performed in this laboratory have been audited by the United Kingdom Accreditation Service (UKAS) and accredited to ISO 15189.
Symbol Ccy Code Bid Ask Share Price (Mid) Previous Close Volume Last Traded
EDX GBX 5 5.25 5.125 5.125 600000 29.11.22

MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.

Key Information

  
Market Cap: £12,855,208
ISIN:GB00BNDMJS47
Par:0.01
Inst Type:Ordinaries
Symbol:EDX
MIFID Status:MTF
Tradable securities in issue:250,833,333
Sector:Pharmaceuticals & Biotechnology
% daily price change:0.00%

Latest Trades

Date & Time Volume Price
29.11.22  |  14:04:491000004.1
29.11.22  |  12:19:501000004.65
29.11.22  |  11:08:102000005.15
29.11.22  |  10:29:412000005.25
22.11.22  |  11:41:271000004.5
22.11.22  |  11:41:081000004.86
18.11.22  |  16:32:491000005
18.11.22  |  12:20:32250005.25
18.11.22  |  11:10:34200005.26
18.11.22  |  10:46:04500005.26

Address

Business Address

EDX Medical Group Plc, Unit 210-211 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, United Kingdom.

Registered Address

201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT, United Kingdom.

Contacts

Corporate Adviser

Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, United Kingdom.

Email: info@pcorpfin.com

Phone: +44 (0)20 7469 0930

Registrar

Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom.

Email: info@nevilleregistrars.co.uk

Phone: +44 (0) 121 585 1131

Research


There is no research available.